Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients

Background: The clinical features of adult-onset atopic dermatitis (AD) are heterogeneous and the diagnosis can be a challenge. A new biologic drug (dupilumab) has been approved for moderate to severe AD in adult patients. The efficacy and safety have been demonstrated in clinical trials, but these...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavecchio, Simona, Angileri, Luisa, Pozzo Giuffrida, Francesco, Germiniasi, Francesca, Marzano, Angelo Valerio, Ferrucci, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564127/
https://www.ncbi.nlm.nih.gov/pubmed/32824992
http://dx.doi.org/10.3390/jcm9092684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564127/
https://www.ncbi.nlm.nih.gov/pubmed/32824992
http://dx.doi.org/10.3390/jcm9092684

Ejemplares similares